PM 02 Adds 1.56 M Shares of Generate Biomedicines, Boosting Institutional Confidence
PM 02’s fresh stake in Generate Biomedicines signals confidence in its mid‑cap oncology pipeline and FDA prospects, offering investors a balanced, institution‑backed biotech opportunity.
4 minutes to read